Literature DB >> 11841810

Biosynthetic studies on the alpha-glucosidase inhibitor acarbose: the chemical synthesis of dTDP-4-amino-4,6-dideoxy-alpha-D-glucose.

Simeon G Bowers1, Taifo Mahmud, Heinz G Floss.   

Abstract

To study the biosynthesis of the pseudotetrasaccharide acarbose, dTDP-4-amino-4,6-dideoxy-alpha-D-glucose (3) was prepared from galactose in 16 steps. After initial protecting-group manipulations, the 6-position of galactose was deoxygenated by hydride displacement of a tosylate. Similarly a tosyl group at the 4-position was displaced upon reaction with sodium azide. Conversion of the resulting glycoside to a glycosyl phosphate was accomplished by reaction of a glycosyl trichloroacetimidate with dibenzyl phosphate. Subsequent removal of the benzyl protecting groups and reduction of the azide by hydrogenation and coupling with an activated nucleoside phosphate gave dTDP-4-amino-4,6-dideoxy-alpha-D-glucose.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841810     DOI: 10.1016/s0008-6215(01)00323-8

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  4 in total

1.  Highly improved acarbose production of Actinomyces through the combination of ARTP and penicillin susceptible mutant screening.

Authors:  Fei Ren; Long Chen; Qunyi Tong
Journal:  World J Microbiol Biotechnol       Date:  2016-11-28       Impact factor: 3.312

2.  A retro-evolution study of CDP-6-deoxy-D-glycero-L-threo-4-hexulose-3-dehydrase (E1) from Yersinia pseudotuberculosis: implications for C-3 deoxygenation in the biosynthesis of 3,6-dideoxyhexoses.

Authors:  Qingquan Wu; Yung-Nan Liu; Huawei Chen; Erich J Molitor; Hung-wen Liu
Journal:  Biochemistry       Date:  2007-02-27       Impact factor: 3.162

3.  Complete biosynthetic pathway to the antidiabetic drug acarbose.

Authors:  Takeshi Tsunoda; Arash Samadi; Sachin Burade; Taifo Mahmud
Journal:  Nat Commun       Date:  2022-06-15       Impact factor: 17.694

4.  Synthesis and biological evaluation of prodrugs of 2-fluoro-2-deoxyribose-1-phosphate and 2,2-difluoro-2-deoxyribose-1-phosphate.

Authors:  Nadege Hamon; Maurizio Quintiliani; Jan Balzarini; Christopher McGuigan
Journal:  Bioorg Med Chem Lett       Date:  2013-03-14       Impact factor: 2.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.